We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GCV
3601
Gabelli Convertible and Income Securities Fund
GCV
$94.7M
$1K ﹤0.01%
+181
New +$851
GDDY icon
3602
GoDaddy
GDDY
$11.5B
$1K ﹤0.01%
17
-2,745
-99% -$96.3K
GENC icon
3603
Gencor Industries
GENC
$212M
$1K ﹤0.01%
+82
New +$1.11K
GF
3604
New Germany Fund
GF
$188M
$1K ﹤0.01%
+46
New +$619
GLDI icon
3605
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
$32.6M
$1K ﹤0.01%
+5
New +$952
GSK icon
3606
GSK
GSK
$106B
$1K ﹤0.01%
27
-2,085
-99% -$103K
GSM icon
3607
FerroAtlántica
GSM
$839M
$1K ﹤0.01%
100
-121
-55% -$1.25K
HOUS
3608
DELISTED
Anywhere Real Estate
HOUS
$1K ﹤0.01%
41
-1,897
-98% -$46.9K
HRTX icon
3609
Heron Therapeutics
HRTX
$92.9M
$1K ﹤0.01%
80
-262
-77% -$4.11K
ILF icon
3610
iShares Latin America 40 ETF
ILF
$3.76B
$1K ﹤0.01%
+53
New +$1.52K
IPWR icon
3611
Ideal Power
IPWR
$74.2M
$1K ﹤0.01%
30
+20
+200% +$882
ISSC icon
3612
Innovative Solutions & Support
ISSC
$361M
$1K ﹤0.01%
+289
New +$940
JNK icon
3613
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.92B
$1K ﹤0.01%
+12
New +$1.31K
KRG icon
3614
Kite Realty
KRG
$5.36B
$1K ﹤0.01%
+23
New +$569
LAB icon
3615
Standard BioTools
LAB
$314M
$1K ﹤0.01%
173
+48
+38% +$301
LGL icon
3616
LGL Group
LGL
$46.5M
$1K ﹤0.01%
268
+146
+120% +$252
LRN icon
3617
Stride
LRN
$3.43B
$1K ﹤0.01%
37
-555
-94% -$8.02K
LSCC icon
3618
Lattice Semiconductor
LSCC
$18.5B
$1K ﹤0.01%
100
-1,151
-92% -$8K
LWAY icon
3619
Lifeway Foods
LWAY
$481M
$1K ﹤0.01%
+100
New +$1.41K
MESO
3620
Mesoblast
MESO
$2.07B
$1K ﹤0.01%
98
-313
-76% -$2.91K
MMT
3621
Aberdeen Multi-Market Income Fund
MMT
$243M
$1K ﹤0.01%
100
-900
-90% -$5.34K
CALY
3622
Callaway Golf Company
CALY
$3.14B
$1K ﹤0.01%
100
-865
-90% -$9.81K
MPB icon
3623
Mid Penn Bancorp
MPB
$952M
$1K ﹤0.01%
43
-726
-94% -$15.3K
MRCY icon
3624
Mercury Systems
MRCY
$6.52B
$1K ﹤0.01%
49
-35
-42% -$994
NEON icon
3625
Neonode
NEON
$16.2M
$1K ﹤0.01%
+60
New +$883
143 144
145
146 147

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.